Cgas-KO
Nomenclature
C57BL/6JSmo-Cgasem1Smoc
Cat. NO.
NM-KO-232748
Strain State
Repository Live
Gene Summary
Gene Symbol
Cgas
Model Description
鉴定报告
DownloadValidation Data
Fig.1 Detection of Cgas expression in the thymus and bladder by RT-PCR. RNA expression of Cgas in Cgas-KO mice by RT-PCR.Wild type: one band at 177 bp with primers F1/R1(mCgas) and one band at 178 bp with primers F/R(mGapdh).Homozygous: one band at 178 bp with primers F/R(mGapdh).
Abbr. M, DNA marker; HO, homozygous; WT, wild type.
Fig.2 Detection of Cgas expression in thymus and bladder by qPCR. RNA expression of Cgas in Cgas-KO mice by qPCR.Mice in LPS group were injected intraperitoneally with a single dose of LPS (5mg/kg) and sacrificed 2 h after administration. Relative expression represents Cgas mRNA levels relative to its average expression in WT mice in control group. (n=2, female, 6-week-old)
Abbr. M, DNA marker; HO, homozygous; WT, wild type.
Fig.3 Detection of Ifnβ1 expression in thymus of the LPS-stimulated Cgas-KO mice by qPCR.mRNA expression of Ifnβ1 in thymus of Cgas-KO mice by qPCR.Relative expression represents Ifnβ1 mRNA levels relative to its average expression in WT mice in control group. (n=2, female, 6-week-old)
Abbr. HO, homozygous; WT, wild type.
Fig.4 Detection of Ifnα2 expression in thymus of the LPS-stimulated Cgas-KO mice by qPCR.RNA expression of Ifnα2 in Cgas-KO mice by qPCR.Relative expression represents Ifnα2 mRNA levels relative to its average expression in WT mice in control group. (n=2, female, 6-week-old)
Abbr. HO, homozygous; WT, wild type.
Fig.5 Detection of mouse cGAS expression in Cgas-KO mice by WB.Expression characterization of mouse cGAS in Cgas-KO mice by WB.Mice in LPS group were injected intraperitoneally with a single dose of LPS (5mg/kg) and sacrificed 2 h after administration.
Abbr. M, marker; WT, wild type; HO, Homozygous; PC, positive control, NIH/3T3 cells.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
